<DOC>
	<DOCNO>NCT02304068</DOCNO>
	<brief_summary>Currently best treatment `` wet '' macular degeneration involve regular injection Ranibizumab ( Lucentis ) . In initial clinical trial , drug inject eye every month . Since number study find similar benefit drug give fix number injection initially injection need . This approach adopt UK , follow recommendation National Institute Clinical Excellence ( NICE ) . Although approach reduces expense risk un-necessary treatment , require regular hospital assessment disease activity determine repeat injection require deferred . The hospital assessment time-consuming , inconvenient large number assessment cause delays hospital follow-up . Using three different assessment criterion monitor disease activity home , investigator plan see home monitoring good hospital assessment . The investigator already identify many patient dislike lengthy hospital assessment visit would welcome opportunity monitor disease activity home . The investigator also show understand complete home assessment test . In pilot project , investigator aim get idea reliable home monitoring small sample 30 patient . The data pilot project generate use influence help plan subsequent , large , national study submit funding National Institute Health Research .</brief_summary>
	<brief_title>The Accuracy Home Monitoring Acute Macular Degeneration ( AMD ) Disease Activity</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<criteria>Patients 60 year clinical diagnosis neovascular agerelated macular degeneration ( ARMD ) , receive treatment intravitreal ranibizumab accordance current UK practice At least 6 month prior treatment beyond load phase three fix injection At least 2 injection prior 6 month maintenance phase treatment Early Treatment Diabetic Retinopathy Study ( ETDRS ) chart letter score 2m 30 70 letter start study Patients chronic intraretinal cycts subretinal fluid study eye Optical coherence tomography ( OCT ) examination despite prior treatment judge stable without need treatment Significant hearing impairment , felt likely interfere train telephone call prior home monitoring Lack inform consent</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>